Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M
|
Luke Timmerman |
11/20/09 |
Boston
|
|
Vertex Turns $109M Debt Into Stock
|
Luke Timmerman |
11/10/09 |
Boston
|
|
ISB Nabs $8M for Cancer Genome
|
Luke Timmerman |
11/10/09 |
Seattle
|
|
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters
|
Luke Timmerman |
11/10/09 |
Seattle
|
|
Helicos Takes Itself Off Block
|
Luke Timmerman |
11/09/09 |
Boston
|
|
Dendreon Burns $28M in Q3
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
SonoSite Sales Drop 13%
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
Omeros, Worst Performing IPO of 2009, Casts Shadow Over Other Aspiring Biotechs
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
Eastbourne Capital Dumps Entire Stake in Amylin After Partial Victory in Proxy Battle
|
Luke Timmerman |
10/09/09 |
San Diego
|
|
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Omeros Raises $68.2M in Washington’s First IPO in Two Years
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Geospiza Wins NIH Cancer Grant
|
Luke Timmerman |
10/07/09 |
Seattle
|
|
Omeros Made Errors on NIH Grant, But Feds Accepted Internal Investigation Saying They Weren’t Overbilled
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
Hutch Pulls In $40M From Stimulus
|
Luke Timmerman |
10/05/09 |
Seattle
|
|
Ironwood Recruits Genentech, Facebook Star as Company Knocks on Wall Street Doors
|
Luke Timmerman |
10/05/09 |
Boston
|
|
UW Gets $25M For Genome Center
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
Teranode Gets $900K Debt Deal
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
The San Diego Biotech Survival Index: Local Firms Make Strong Rebound In First Half of 2009
|
Luke Timmerman |
09/23/09 |
San Diego
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Calypso Medical Raises $50M to Strengthen Pinpointed Radiation Therapy for Cancer
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
Omeros Moves Closer To IPO, Sets Price Goal
|
Luke Timmerman |
09/16/09 |
Seattle
|
|
State Hands Out $5.1M Biotech Grants
|
Luke Timmerman |
09/15/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say
|
Luke Timmerman |
08/26/09 |
Seattle
|
|
AVI Nails Down $30M
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
